More on TEVA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $39.31 |
|
|||
| Open | $39.31 | ||||
| 52 Wk High | $66.55 | ||||
| 52 Wk Low | $37.82 | ||||
| Day High | $39.81 | ||||
| Day Low | $39.05 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,775,005 | ||||
- TD Cowen Starts Teva Pharma (TEVA) at Buy
- Samsung Bioepis and Teva expand biosimilar partnership to six candidates
- Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
- TAPI appoints Serge Rogasik as chief executive officer
- TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness
- FDA approves Teva's Degevma as biosimilar to Xgeva
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
- Form 8-K TEVA PHARMACEUTICAL INDU For: Sep 14
- Form 4 TEVA PHARMACEUTICAL INDU For: Sep 18 Filed by: Savage Brian
- Form 4 TEVA PHARMACEUTICAL INDU For: Sep 19 Filed by: MIGNONE ROBERTO
Entities mentioned with TEVA
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Citi | View Related Stories »
- Options | View Related Stories »
- JPMorgan | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
